Shuang Tong

机构：Ningbo Municipal People's Government

发表论文 27 篇 · 总被引 513 次 · h-index 12

代表论文

• Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 131)
• Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer (2022 · Journal for ImmunoTherapy of Cancer · 被引 106)
• First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study (2024 · Signal Transduction and Targeted Therapy · 被引 43)
• Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions (2015 · Journal of Craniofacial Surgery · 被引 23)
• Tissue-specific expression of the NOD-like receptor protein 3 in BALB/c mice (2014 · Journal of Veterinary Science · 被引 23)
• H9N2 avian influenza infection altered expression pattern of Sphiogosine-1-phosphate Receptor 1 in BALB/c mice (2013 · Virology Journal · 被引 19)